NCT02784795 2025-08-21
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Phase 1 Terminated
Eli Lilly and Company
Louisiana State University Health Sciences Center Shreveport
Centre Jean Perrin
National Cancer Center, Korea
Vanderbilt-Ingram Cancer Center
Washington University School of Medicine
SWOG Cancer Research Network